Q4 2023

Filed Apr 15, 2024 · 10-K · 106 days after period end · 0001213900-24-032898

Q4 2023 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net Income

-$193.69K

derivedN/M vs Q4 2022

EPS, diluted—Not derived. Share counts vary by quarter.

Gross Profitderived-$18,996N/M

Same quarter

Metric	Q4 2023derived from reported figures	Q4 2022derived from reported figures	Q4 2021derived from reported figures	Q4 2020derived from reported figures
Revenue	—	—	$213.04K	$218.93K
Net Income	-$193.69K	-$213.13K	-$90.63K	-$89.54K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR